- Home
- CELC vs VCV Comparison
CELC vs VCV Comparison
Compare CELC & VCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- VCV
- Stock Information
- Founded
- CELC 2011
- VCV 1993
- Country
- CELC United States
- VCV United States
- Employees
- CELC N/A
- VCV N/A
- Industry
- CELC Medical Specialities
- VCV Trusts Except Educational Religious and Charitable
- Sector
- CELC Health Care
- VCV Finance
- Exchange
- CELC Nasdaq
- VCV Nasdaq
- Market Cap
- CELC 489.7M
- VCV 501.9M
- IPO Year
- CELC 2017
- VCV N/A
- Fundamental
- Price
- CELC $10.93
- VCV $10.80
- Analyst Decision
- CELC Strong Buy
- VCV
- Analyst Count
- CELC 6
- VCV 0
- Target Price
- CELC $29.17
- VCV N/A
- AVG Volume (30 Days)
- CELC 356.6K
- VCV 107.9K
- Earning Date
- CELC 11-14-2024
- VCV 01-01-0001
- Dividend Yield
- CELC N/A
- VCV 4.09%
- EPS Growth
- CELC N/A
- VCV N/A
- EPS
- CELC N/A
- VCV 0.13
- Revenue
- CELC N/A
- VCV N/A
- Revenue This Year
- CELC N/A
- VCV N/A
- Revenue Next Year
- CELC N/A
- VCV N/A
- P/E Ratio
- CELC N/A
- VCV $75.82
- Revenue Growth
- CELC N/A
- VCV N/A
- 52 Week Low
- CELC $10.35
- VCV $8.05
- 52 Week High
- CELC $22.19
- VCV $10.40
- Technical
- Relative Strength Index (RSI)
- CELC 35.65
- VCV 48.04
- Support Level
- CELC $10.35
- VCV $10.75
- Resistance Level
- CELC $13.80
- VCV $10.92
- Average True Range (ATR)
- CELC 0.83
- VCV 0.17
- MACD
- CELC -0.19
- VCV -0.04
- Stochastic Oscillator
- CELC 16.20
- VCV 18.85
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.